Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca to present new cardiovascular, renal drug data in US

31st Oct 2022 12:05

(Alliance News) - AstraZeneca PLC on Monday said it will present new data on cardiovascular and renal disease drugs in the US between Thursday and Monday next week. Read More

AstraZeneca's Ultomiris treatment gets good results from Phase 3 trial

27th Oct 2022 10:58

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 trial results for its Ultomiris treatment showed a "significant" reduction in the risk of relapse in adults with neuromyelitis optica spectrum disorder. Read More

Study confirms AstraZeneca jab's higher risk of very rare clot

27th Oct 2022 06:11

(Alliance News) - AstraZeneca PLC's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer Inc jab, a large international study said Thursday. Read More

TOP NEWS: AstraZeneca hails survival rates of breast cancer drugs

26th Oct 2022 09:36

(Alliance News) - AstraZeneca PLC on Wednesday said its breast cancer drugs capivasertib and camizestrant significantly improved progression-free survival in a phase 3 and 2 trial respectively. Read More

LONDON MARKET OPEN: Sterling climbs above USD1.15, euro above parity

26th Oct 2022 08:49

(Alliance News) - London's FTSE 100 index moved lower at the open on Wednesday, as the pound continued to climb higher on the potential for the stability that a Rishi Sunak premiership could bring to Westminster. Read More

TOP NEWS: AstraZeneca's Fasenra fails to meet trial's primary endpoint

25th Oct 2022 08:24

(Alliance News) - AstraZeneca PLC on Tuesday said that its Fasenra treatment failed to meet one of its two primary endpoints in its Messina Phase 3 trial in eosinophilic esophagitis. Read More

AstraZeneca treatment gets FDA approval for US liver cancer patients

24th Oct 2022 08:23

(Alliance News) - AstraZeneca PLC on Monday said one of its treatments has been approved in the US for treating adults with unresectable liver cancer. Read More

TOP NEWS: AstraZeneca says Evusheld shows promise on Covid variants

20th Oct 2022 09:06

(Alliance News) - AstraZeneca PLC on Thursday said that new analyses from a phase 3 treatment trial show the potential of its Covid drug Evusheld to reduce severity and mortality. Read More

LONDON BROKER RATINGS: HSBC lifts Marston's; Barclays cuts Flutter

19th Oct 2022 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET CLOSE: Stocks down as BoE confirms end to bond-buying

12th Oct 2022 17:00

(Alliance News) - Stock prices in London closed in the red on Wednesday, as discouraging economic data and mixed signals from the UK's central bank weighed on investor sentiment. Read More

AstraZeneca to show 'exceptional' data on neuromyelitis drug Ultomiris

12th Oct 2022 10:47

(Alliance News) - AstraZeneca PLC on Wednesday said its subsidiary Alexion Pharmaceuticals Inc, which focuses on rare diseases, will publish "new data showing significant advances" regarding the treatment for a form of neuromyelitis with its drug Ultomiris. Read More

Illumina collaborates with AstraZeneca on AI-focused research

12th Oct 2022 07:23

(Alliance News) - Illumina Inc on Tuesday said it is collaborating with AstraZeneca PLC on drug target discovery, with a focus on artificial intelligence-based research on genes. Read More

LONDON BROKER RATINGS: GSK raised to 'outperform'; RBC cuts THG

29th Sep 2022 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

TOP NEWS: AstraZeneca's Tezspire and Koselugo approved in Japan

27th Sep 2022 09:25

(Alliance News) - AstraZeneca PLC on Tuesday said its Tezspire and Koselugo drugs have been approved in Japan for the treatment of severe asthma and patients that suffer from a rare genetic condition, respectively. Read More

TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May

26th Sep 2022 08:55

(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire. Read More

TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis

23rd Sep 2022 08:19

(Alliance News) - AstraZeneca PLC on Friday said its Ultomiris drug has been approved in the EU to treat myasthenia gravis, a condition which causes muscle weakness. Read More

LONDON BRIEFING: Smiths annual revenue rises; Made.com up for sale

23rd Sep 2022 07:43

(Alliance News) - European markets are set to end a difficult week in decent fashion on Friday, as investors take onboard a series of hawkish central bank moves. Read More

TOP NEWS: AstraZeneca's Lynparza approved in China for ovarian cancer

22nd Sep 2022 08:41

(Alliance News) - AstraZeneca PLC on Thursday, along with pharmaceutical peer Merck & Co Inc, said that Lynparza has been approved in China for the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. Read More

LONDON BRIEFING: Lower call; JD Sports suffers interim profit fall

22nd Sep 2022 07:46

(Alliance News) - Stocks in London are set to open lower on Thursday, ahead of a major interest rate decision by the Bank of England and a day after the US Federal Reserve settled for another three-quarter-point rate hike. Read More

WPP grows in Latin America with JeffreyGroup acquisition

21st Sep 2022 15:31

(Alliance News) - Advertising company WPP PLC said it has boosted its Latin American presence with a deal to acquire JeffreyGroup. Read More

FTSE 100 Latest

Value10,585.91

Change61.15